FDA moves to fast-track 3 psychedelic drugs for review
Digest more
The Trump administration’s moves on marijuana and psychedelics signal the start of a new era in Republican drug policy. The ...
EO authorizes the VA to accelerate research and improve access to psychedelic drugs for the treatment of veterans with ...
A new study from the University of Victoria (UVic) has identified a segment of traumatic brain injury survivors who are using ...
President Trump’s executive order loosening research restrictions on psychedelic medicine, which was kick-started by a text ...
Natural psychoactive compounds have gained traction as possible treatments for mental illnesses, brain injuries, dementia and ...
With the White House’s recent embrace of research into psychedelics, it’s time for Jews to embrace the healing they can ...
President Donald Trump has directed his administration to speed up reviews of certain psychedelic drugs, including ibogaine.
Compass Pathways is already in the final stage of development on a psychedelic medicine to treat depression.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results